This is probably due to the low levels of both membrane and soluble TRAIL basally expressed by pIL6-TRAIL+-GFP+-UC-MSCs, since the transcription of TRAIL is reinforced by both IL-1α and IL-1β usually abundant within the tumor sites. This evidence concerns the gene TNFSF10 and neoplasm.